Your browser doesn't support javascript.
loading
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE.
Goldschmidt, Hartmut; Baertsch, Marc-Andrea; Schlenzka, Jana; Becker, Natalia; Habermehl, Christina; Hielscher, Thomas; Raab, Marc-Steffen; Hillengass, Jens; Sauer, Sandra; Müller-Tidow, Carsten; Luntz, Steffen; Jauch, Anna; Hose, Dirk; Seckinger, Anja; Brossart, Peter; Goerner, Martin; Klein, Stefan; Schmidt-Hieber, Martin; Reimer, Peter; Graeven, Ullrich; Fenk, Roland; Haenel, Mathias; Martin, Hans; Lindemann, Hans W; Scheid, Christoph; Nogai, Axel; Salwender, Hans; Noppeney, Richard; Besemer, Britta; Weisel, Katja.
Afiliação
  • Goldschmidt H; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany. hartmut.goldschmidt@med.uni-heidelberg.de.
  • Baertsch MA; National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. hartmut.goldschmidt@med.uni-heidelberg.de.
  • Schlenzka J; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Becker N; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Habermehl C; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Hielscher T; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Raab MS; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Hillengass J; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Sauer S; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Müller-Tidow C; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Luntz S; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Jauch A; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Hose D; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Seckinger A; National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Brossart P; Coordination Centre for Clinical Trials (KKS), University Hospital Heidelberg, Heidelberg, Germany.
  • Goerner M; Institute for Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Klein S; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Schmidt-Hieber M; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Reimer P; Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, Med. Klinik und Poliklinik III, University Hospital Bonn, Bonn, Germany.
  • Graeven U; Department of Hematology, Oncology and Palliative Care, Community Hospital Bielefeld, Bielefeld, Germany.
  • Fenk R; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Haenel M; Clinic for Hematology and Stem Cell Transplantation, Helios-Hospital Berlin Buch, Berlin, Germany.
  • Martin H; Clinic for Hematology and Oncology, Carl-Thiem Klinikum Cottbus, Cottbus, Germany.
  • Lindemann HW; Department of Hematology, Oncology and Stem Cell Transplantation, Evangelisches Krankenhaus Essen-Werden gGmbH, Essen, Germany.
  • Scheid C; Department of Hematology, Oncology and Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany.
  • Nogai A; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Duesseldorf, Germany.
  • Salwender H; Department of Hematology, Oncology and Stem Cell Transplantation, Klinikum Chemnitz GmbH, Chemnitz, Germany.
  • Noppeney R; Department of Hematology and Oncology, Goethe University, Frankfurt, Germany.
  • Besemer B; Department of Hematology and Oncology, Kath. Krankenhaus Hagen gem. GmbH, Hagen, Germany.
  • Weisel K; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
Leukemia ; 35(4): 1134-1144, 2021 04.
Article em En | MEDLINE | ID: mdl-32694619
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha